trifluoperazine has been researched along with Cardiotoxicity in 1 studies
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goda, AE | 1 |
| Elenany, AM | 1 |
| Elsisi, AE | 1 |
1 other study available for trifluoperazine and Cardiotoxicity
| Article | Year |
|---|---|
Novel in vivo potential of trifluoperazine to ameliorate doxorubicin-induced cardiotoxicity involves suppression of NF-κB and apoptosis.
Topics: Animals; Apoptosis; Cardiotoxicity; Cardiotoxins; Caspase 3; Doxorubicin; Male; Mice; Myocardium; Tr | 2021 |